Press Releases
Friends of Cancer Research Statement Thanking Dr. Janet Woodcock for Service as Acting FDA Commissioner
Friends of Cancer Research (Friends) would like to thank Dr. Janet Woodcock for serving as Acting Commissioner of the Food and Drug Administration (FDA) and
Statement from Friends of Cancer Research on Dr. Robert Califf’s Confirmation as FDA Commissioner
Friends of Cancer Research (Friends) would like to congratulate Dr. Robert Califf on his bipartisan confirmation today as FDA Commissioner. The United States is at
New HRD Publication Sets the Stage for Unique Collaboration
Friends of Cancer Research (Friends) is excited to announce its latest publication “Homologous Recombination Deficiency: Concepts, Definitions, and Assays.” Findings from this manuscript set the
Friends of Cancer Research Announces Results from Phase 2 of Tumor Mutational Burden Harmonization Project
Washington, DC – Friends of Cancer Research (Friends) is pleased to announce findings from the final analysis of our TMB Harmonization Project published this week
Individuals with Cancer Must Be Included in COVID-19 Vaccine Trials
New ASCO-Friends Joint Position Statement Encourages Enrollment of Patients with Cancer in Vaccine Studies Alexandria, Va. and Washington, DC. – Individuals with cancer or a
Friends of Cancer Research Launches Step 2 of the ctMoniTR Project
Washington, DC – June 8, 2021 – Friends of Cancer Research (Friends) is proud to announce the launch of Step 2 of the ctDNA for Monitoring
Dr. Patrizia Cavazzoni named director of the Center for Drug Evaluation and Research at U.S. FDA
Washington, DC – April 12, 2021 – Friends of Cancer Research would like to congratulate Dr. Patrizia Cavazzoni for being named the director of the
Janet Woodcock Named Acting FDA Commissioner
Washington, DC – January 20, 2021 – Friends of Cancer Research (Friends) would like to applaud President Biden for selecting Dr. Janet Woodcock to serve
STATEMENT: Support for FDA is Essential – A Vaccine Must Not Be Politicized
Washington, DC – December 2, 2020 – Friends of Cancer Research (Friends) praises the scientific endeavor that has unfolded during the past months to discover
New COVID-19 Diagnostics Evidence Accelerator Applies Real-World Data to Answer Urgent Questions on SARS-CoV-2 Testing
Washington, DC – Today, the Reagan-Udall Foundation for the FDA, in collaboration with Friends of Cancer Research, announce the COVID-19 Diagnostics Evidence Accelerator, a multi-stakeholder,
